Treatment duration for MRSA pneumonia depends on severity, speed of clinical response, presence of complications, and the patient’s immune status. There is no single universal “standard number of days”; some cases stabilize relatively quickly, while severe or complicated infections require longer therapy. The management plan is built around selecting an appropriate antibiotic regimen and closely monitoring clinical and laboratory response. Key improvement signals include resolution of fever, easier breathing, and reduced oxygen requirements. Because MRSA pneumonia can be high-risk, antibiotic choice and duration must be individualized by a clinician. For personal treatment timelines, medical evaluation is essential.